ArticleExperimental and therapeutic medicine2025
Bartholin's gland cyst with markedly elevated CA19-9 level: A case report.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report describes a 43-year-old woman who presented with a symptomatic left Bartholin's gland cyst accompanied by a markedly elevated serum CA19-9 levels (>1,000 U/ml). Despite initial concerns for malignancy, comprehensive evaluation, including contrast-enhanced CT and serial biomarker monitoring, revealed rapid CA19-9 normalization (83% reduction within 24 h post-marsupialization), reaching the normal range by day 59 post-drainage, suggesting an inflammatory etiology. This case underscores two key clinical insights: CA19-9 elevations exceeding 1,000 U/ml may occur in benign mucinous cysts and short-interval biomarker reassessment aids in differential diagnosis. These findings expand the current understanding of tumor marker dynamics in benign gynecological pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.